Morgan Stanley’s $177 target on MRK

MRK Merck & Co.

$143 → $177 (+24%) by Oct 2027

Overweight · lowers · said Oct 7, 2026 · 12-month default horizon

Open: judged on the close on Oct 7, 2027

The article this target came from

Merck & Co., Inc. (NYSE:MRK) Stock Price Target Lowered at Morgan Stanley

MarketBeat · Oct 7, 2026

Morgan Stanley cut their price target on shares of Merck & Co., Inc. from $179.00 to $177.00

Morgan Stanley’s track record → Merck & Co. →

A fact about what Morgan Stanley published, as reported by MarketBeat, not a recommendation from Dalsna Finance; Morgan Stanley is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.